AbCelex core proprietary Technology Platform comprises a targeted protein feed additive approach with a demonstrated potential to establish a new paradigm in preventing and treating a number of bacterial infections at source in livestock.
AbCelex is currently developing several feed additive candidates against a number of microbial infections in broiler chickens. AbCelex’s lead product, NF-220, comprises a number of novel sdAb-based protein fragments with the potential to significantly reduce Campylobacter jejuni colonization and gastroenteritis in the GI tract of broiler when given as a feed additive or in drinking water.
Campylobacter jejuni is a food-borne pathogen commonly present in the poultry gut. Campylobacter is the leading global cause of food-borne illness, and a rising public health concern. Our results to-date have demonstrated an above 2 log reduction in the rate of Campylobacter jejuni colonization in the GI tract of broiler chickens treated with our products.
Additional sdAb-based protein fragments targeted at zoonotic bacteria with human health implications are under development at this time.